Showing results (621-630 of 829) with videos related to

Sort By:
Pageof 83
BMC Infectious Diseases|December 5, 2018
Estimating the incidence of norovirus acute gastroenteritis among US and European international travelers to areas of moderate to high risk of traveler's diarrhea: a prospective cohort study protocolLisa Lindsay, Herbert L DuPont, Christine L Moe, et al.
American Journal of Epidemiology|June 1, 1988
Illness and reservoirs associated with Giardia lamblia infection in rural Egypt: the case against treatment in developing world environments of high endemicityP S Sullivan, H L DuPont, R R Arafat, et al.
Journal of Travel Medicine|September 8, 2011
A randomized, double-blind, pilot study of rifaximin 550 mg versus placebo in the prevention of travelers' diarrhea in Mexico during the dry seasonJose Flores, Herbert L Dupont, Zhi-Dong Jiang, et al.
Plastic and Reconstructive Surgery|December 4, 2004
Breast cancer in patients with prior augmentation: presentation, stage, and lymphatic mappingJames W Jakub, Mark D Ebert, Alan Cantor, et al.
Archives of General Psychiatry|May 1, 1988
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatmentJ C Ballenger, G D Burrows, R L DuPont, et al.
Journal of Clinical Psychopharmacology|October 1, 1992
Discontinuation of alprazolam after long-term treatment of panic-related disordersR L DuPont, R P Swinson, J C Ballenger, et al.
Journal of Travel Medicine|December 19, 2008
Enterotoxigenic Escherichia coli and diffusely adherent E. coli as likely causes of a proportion of pathogen-negative travelers' diarrhea--a PCR-based studyIsmail M Meraz, Zhi-Dong Jiang, Charles D Ericsson, et al.
Clinical and Diagnostic Laboratory Immunology|February 10, 1998
HEp-2 cell-adherent Escherichia coli and intestinal secretory immune response to human immunodeficiency virus (HIV) in outpatients with HIV-associated diarrheaJ J Mathewson, B M Salameh, H L DuPont, et al.
Archives of General Psychiatry|May 1, 1988
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safetyR Noyes, R L DuPont, J C Pecknold, et al.
Journal of Clinical Gastroenterology|January 23, 2016
Development and Validation of a Clostridium difficile Health-related Quality-of-Life QuestionnaireKevin W Garey, Samuel L Aitken, Liliane Gschwind, et al.
Pageof 83